China
Africa
Explore chapters and articles related to this topic
Knowledge Area 3: Surgical Procedures
Published in Rekha Wuntakal, Ziena Abdullah, Tony Hollingworth, Get Through MRCOG Part 1, 2020
Rekha Wuntakal, Ziena Abdullah, Tony Hollingworth
b. 1 in 200 procedures Further readingRoyal College of Obstetricians and Gynaecologists (RCOG). Consent Advice No. 3. Female sterilization. February 2016.
SBA Answers
Published in Justin C. Konje, Complete Revision Guide for MRCOG Part 2, 2019
B 1:200Vasectomy has a lower failure rate after proven azoospermia (1:2000) and lower complication rates, although chronic post-vasectomy pain occurs in up to 14% of men. Female sterilization has a failure rate of 1:200. (Bakour SH et al. Contraceptive methods and issues around the menopause – An evidence update. The Obstetrician & Gynaecologist 2017; 19: 289–297)
Fertility and Cancer
Published in Jane M. Ussher, Joan C. Chrisler, Janette Perz, Routledge International Handbook of Women’s Sexual and Reproductive Health, 2019
Michelle Peate, Lesley Stafford, Yasmin Jayasinghe
Some women will opt not to have children after cancer treatment. Concerns about how to best avoid pregnancy have been reported, with hormonal contraception considered unsafe and male sterilisation thought undesirable (Connell et al., 2006; Thewes, Butow, Girgis, & Pendlebury, 2004). Failed contraception has been linked to anxiety and fear of recurrence (Connell et al., 2006). Hormonal contraception (e.g., the contraceptive pill or implants) is often contraindicated in women with hormone responsive cancers. Therefore, it is recommended that these women use non-hormonal forms of contraception such as barrier methods (e.g., condoms, diaphragms, intrauterine contraceptive devices), or male or female sterilisation.
Understanding the role of female sterilisation in Indian family planning through qualitative analysis: perspectives from above and below
Published in Sexual and Reproductive Health Matters, 2022
Sharmada Sivaram, Sunita Singh, Loveday Penn-Kekana
Female sterilisation “remains the most popular modern contraceptive method”.27 On whether this reflects voluntary demand, one key informant referred to their experience with southern Indian states. They explained that over a couple of generations, a level of social acceptance for sterilisation was built as a result of health workers achieving targets under tremendous pressure in the 1980s in Tamil Nadu and Kerala. Newer generations preferred to opt for it as it worked for their mothers’ generation. “You get married, you immediately have a child, you have a second child as soon as you can and then you have sterilisation. That’s the kind of socially accepted” … (Academic researcher)
Sexual and reproductive health among adolescent girls and young women in Mombasa, Kenya
Published in Sexual and Reproductive Health Matters, 2020
Andrea Wilson, Helgar Musyoki, Lisa Avery, Eve Cheuk, Peter Gichangi, Parinita Bhattacharjee, Janet Musimbe, Stella Leung, James Blanchard, Stephen Moses, Sharmistha Mishra, Marissa Becker
Modern female-controlled non-barrier methods of contraception included female sterilisation, birth control pills, IUD, injectables and implants. Dual contraception use was defined as at least one modern female-controlled non-barrier method and condoms. Unsafe abortion was defined as abortions completed under unsafe conditions: participant’s home, someone else’s home or unlicensed clinic. Safe abortions were defined as abortions completed in a public/government facility or private, non-governmental, community- or faith-based organisation (NGO/CBO/FBO) facility. Births completed in public/government facilities or private/NGO/CBO/FBO were considered to have been attended by a skilled health professional.
The Effects of Hormonal and Non-Hormonal Intrauterine Devices on Female Sexual Function: A Systematic Review
Published in International Journal of Sexual Health, 2023
Katherine Ogle, Ariel B. Handy
Fifteen articles in this review measured the effects of IUDs on sexual satisfaction. For these fifteen papers, seven were considered high quality and eight were considered moderate quality. Nine studies reported neutral effects (Bastianelli et al., 2011; Halmesmäki et al., 2007; Hurskainen et al., 2004; Koseoglu et al., 2016; Li et al., 2004; Sakinci et al., 2016; Suhonen et al., 2004; Toorzani et al., 2010; Umran & Melike, 2016). No significant between-group differences were found among women using various IUDs compared to those using condoms, OCPs, withdrawal methods, and tubal sterilization ( Toorzani et al., 2010; Umran & Melike, 2016; c.f. Fataneh et al., 2013 ). No notable differences in sexual satisfaction were found between Cu-IUD users and women using no form of contraceptives (Koseoglu et al., 2016; Sakinci et al., 2016). Li et al. (2004) found no significant differences in sexual satisfaction among Hong Kong Chinese women before and three to four months after insertion of an IUD (Cu- or LNG-IUDs; n = 96), and initiation of OCPs (n = 87), and injectables (n = 67). However, they did find significant improvement after three to four months in women who had undergone female sterilization (n = 111). Among women treated for menorrhagia with either a hysterectomy or LNG-IUD, no significant change in satisfaction was noted in the LNG-IUD group from pre-insertion to 5-years post-insertion, though, there was an increase in satisfaction in the hysterectomy group in the same time frame (Halmesmäki et al., 2007). No changes in satisfaction were also noted from 0- to 12-months of continuous use in LNG-IUD and OCP users (Bastianelli et al., 2011; Suhonen et al., 2004).